What Would Full FDA Approval of Pfizer’s COVID Vaccine Mean for the Stock?

The clock is now ticking for a Food and Drug Administration decision on full approval for the COVID-19 vaccine developed by Pfizer(NYSE:PFE) and BioNTech(NASDAQ:BNTX). The vaccine is currently on the market in the U.S. under the FDA’s Emergency Use Authorization…

Click here to view the original article.